<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/ECC4AE63-043A-466C-AA93-E53966151786"><gtr:id>ECC4AE63-043A-466C-AA93-E53966151786</gtr:id><gtr:name>APS Biocontrol Limited</gtr:name><gtr:address><gtr:line1>7D Muirdrum</gtr:line1><gtr:city>Carnoustie</gtr:city><gtr:postCode>DD7 6LE</gtr:postCode><gtr:region>Scotland</gtr:region></gtr:address><gtr:typeInd>P</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/ECC4AE63-043A-466C-AA93-E53966151786" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>ECC4AE63-043A-466C-AA93-E53966151786</gtr:id><gtr:name>APS Biocontrol Limited</gtr:name><gtr:address><gtr:line1>7D Muirdrum</gtr:line1><gtr:city>Carnoustie</gtr:city><gtr:postCode>DD7 6LE</gtr:postCode><gtr:region>Scotland</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>173815.0</gtr:offerGrant><gtr:projectCost>386258.0</gtr:projectCost></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/04B5FC88-3F4F-45F2-9AE9-B7CD44EC72BE" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>04B5FC88-3F4F-45F2-9AE9-B7CD44EC72BE</gtr:id><gtr:name>Biorationale Limited</gtr:name><gtr:address><gtr:line1>RIVERSIDE HOUSE , LADHOPE VALE</gtr:line1><gtr:city>GALASHIELS</gtr:city><gtr:postCode>TD1 1BT</gtr:postCode><gtr:region>Scotland</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>2893.0</gtr:offerGrant><gtr:projectCost>6428.0</gtr:projectCost></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E8B4AAB7-8E53-43E9-873C-CB43C9A16112" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>E8B4AAB7-8E53-43E9-873C-CB43C9A16112</gtr:id><gtr:name>Monaghan Mushrooms Limited</gtr:name><gtr:address><gtr:line1>Stock Lane</gtr:line1><gtr:city>Langford</gtr:city><gtr:postCode>BS40 5ES</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>68516.0</gtr:offerGrant><gtr:projectCost>195759.0</gtr:projectCost></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/6BAA32D3-0592-4662-8707-B8FF49287B99"><gtr:id>6BAA32D3-0592-4662-8707-B8FF49287B99</gtr:id><gtr:firstName>Unknown</gtr:firstName><gtr:otherNames>Unknown</gtr:otherNames><gtr:surname>Unknown</gtr:surname><gtr:roles><gtr:role><gtr:name>PROJECT_MANAGER</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=102277"><gtr:id>212DA6AC-980F-4368-AFED-D56A56DE8E98</gtr:id><gtr:title>Innovative and Sustainable Control of Mushroom Blotch</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Collaborative R&amp;D</gtr:grantCategory><gtr:grantReference>102277</gtr:grantReference><gtr:abstractText>The UK mushroom market is facing fierce competition from EU growers and rising operating costs; imports now make up 55% of the UK marketed total. A novel competitive advantage would provide an important boost to the UK industry and this application aims to provide this through tackling one of the most serious bacterial disease of mushrooms; bacterial blotch, which is responsible for crop losses of up to 10% (&amp;pound;20M industry losses). This project will build on proof-of-concept data from a previous TSB feasibility project in which an innovative biocontrol technology based on naturally-occurring antimiciobial agents (bacteriophage) was shown to control bacterial-induced mushroom blotch symptoms in the laboratory. A business-led consortium will carry out further invesigations on the technology, addressing key questions of technology deployment and efficacy, together with formulation and integration into commercial practice.</gtr:abstractText><gtr:fund><gtr:end>2018-05-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/E18E2F0F-AC7D-4E02-9559-669F7C8FEC74"><gtr:id>E18E2F0F-AC7D-4E02-9559-669F7C8FEC74</gtr:id><gtr:name>Innovate UK</gtr:name></gtr:funder><gtr:start>2015-06-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>245224</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">102277</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>